Results 141 to 150 of about 45,635 (259)

Safety, Tolerability, and Immunogenicity of Measles and Rubella Vaccine Delivered with a High-Density Microarray Patch: Results from a Randomized, Partially Double-Blinded, Placebo-Controlled Phase I Clinical Trial. [PDF]

Vaccines (Basel), 2023
Baker B, Bermingham IM, Leelasena I, Hickling J, Young PR, Muller DA, Forster AH.   +6 more
europepmc   +1 more source

Varicella Immunogenicity with 1‐ and 2‐Dose Regimens of Measles‐Mumps‐Rubella‐Varicella Vaccine [PDF]

, 2008
Henry R. Shinefield, Steve Black, Barbara J. Kuter   +2 more
openalex   +1 more source

Replication of rubella vaccine population genetic studies: Validation of HLA genotype and humoral response associations

, 2009
Inna G. Ovsyannikova, Robert M. Jacobson, Robert A. Vierkant, Megan M. O’Byrne, Gregory A. Poland   +4 more
openalex   +1 more source

Measles-rubella vaccine-associated MOG-antibody positive acute demyelinating encephalomyelitis with optic neuritis in a child. [PDF]

Ther Adv Vaccines Immunother, 2022
Otiv M, Botre A, Shah P.
europepmc   +1 more source

Rubella infection after orthotopic liver transplantation [PDF]

, 1994
Green, Michael, Mazariegos, George V., Nour, Bakr, Reyes, Jorge, Starzl, Thomas E., Tzakis, Andreas   +5 more
core   +1 more source

The immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine when co-administered with conjugated meningococcal C vaccine to healthy children: A phase IIIb, randomized, multi-center study in Italy

, 2016
Paolo Durando, Susanna Esposito, Gianni Bona, Mario Cuccia, Maria Giuseppina Desole, Giuseppe Ferrera, Giovanni Gabutti, Angelo Pellegrino, Filippo Salvini, Ouzama Henry, Michael Povey, Federico Marchetti   +11 more
openalex   +1 more source

Estimated Current and Future Congenital Rubella Syndrome Incidence with and Without Rubella Vaccine Introduction - 19 Countries, 2019-2055. [PDF]

MMWR Morb Mortal Wkly Rep
Lebo E, Vynnycky E, Alexander JP, Ferrari MJ, Winter AK, Frey K, Papadopoulos T, Grant GB, O'Connor P, Reef SE, Crowcroft NS, Zimmerman LA.   +11 more
europepmc   +1 more source

Corrigendum to "Examination of scenarios introducing rubella vaccine in the Democratic Republic of the Congo" [Vaccine: X 9 (2021) 100127]. [PDF]

Vaccine X, 2022
Cheng A, Frey K, Mwamba GN, McCarthy KA, Hoff NA, Rimoin AW.   +5 more
europepmc   +1 more source

Comparative Immunogenicity and Safety of Measles-Mumps-Rubella Vaccine When Administered Using Needle Free Injection System to That with Conventional Needle-Syringe in India: A Randomized, Parallel Group Study. [PDF]

Med Devices (Auckl)
Ratta BS, Naik A, Mutha S.
europepmc   +1 more source